News

Meet us at BIOCHINA 2025! Challenge IM is gearing up for Asia’s premier biotech event, and we’d love to connect with partners, investors, and innovators.

• Explore our fully automated tangential flow filtration systems
• Discuss collaboration opportunities
• Stay ahead of industry trends
• Booth: C1-111-112
• March 12-15, Suzhou

Reach out at service@challengeim.com. See you at BIOCHINA 2025!

Chengdu, January 2025– Chengdu UCELLO Biotech Co., Ltd. has recently announced that its self-developed CD19-targeted chimeric antigen receptor (CAR) allogeneic universal T cell therapy, UC101, has received approval from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application on January 11, 2025.

Beijing, January 9, 2024 – Challenge Intelligent Manufacturing (Beijing) Technology Co., Ltd. proudly announces its certification as a "High-Tech Enterprise" by Beijing authorities, following the fourth batch of certified high-tech enterprises in 2023.

Beijing, October 10, 2024 – Challenge Intelligent Manufacturing (Beijing) Technology Co., Ltd. has successfully completed a tens of millions of RMB angel round of financing. The round was led by Huatai GenScript, Tsing Innovation Capital, and Dao Capital, with Index Capital serving as the exclusive financial advisor.

Shanghai, November 2024 – Challenge Intelligent Manufacturing (Beijing) Technology Co., Ltd. made a significant impact at Analytica China 2024 in Shanghai recently, where it showcased its advanced bioprocessing technology and state-of-the-art tangential flow filtration (TFF) systems.

Beijing, October 2024 – Challenge Intelligent Manufacturing (Beijing) Technology Co., Ltd. has introduced its innovative Smart Series, a new line of products designed to streamline and enhance the filtration process within the biopharmaceutical sector.